🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study will include newly-diagnosed AML patients, not suffering acute pr...
Status
Unknown
Location
Weill Cornell Medicine
Start Date
2017-07-03
Trial ID
NCT03257241
Treatments Being Tested
The overall aim of this study is to determine if epigenetic priming with a ...
Status
Active Not Recruiting
Location
Children's Hospital of Central California
Start Date
2017-06-15
Trial ID
NCT03164057
The primary aim of this study is: • To analyze the efficacy (in order to e...
Status
Completed
Location
Hospital Universitario de Salamanca
Start Date
2008-04
Trial ID
NCT00651781
Treatments Being Tested
Although the response rate by first-line treatment has been improved, most ...
Status
Completed
Location
Institute of Harbin Hematology Oncology
Start Date
2015-07-10
Trial ID
NCT03123887
Treatments Being Tested
Donor Lymphocyte Infusion (DLI) following salvage chemotherapy is the one o...
Status
Completed
Location
Washington University School of Medicine
Start Date
2017-10-23
Trial ID
NCT03068819
Treatments Being Tested
In this multi-center, open-label, no control,prospective clinical trial, a ...
Status
Withdrawn
Location
HBDH
Start Date
2018-07-01
Trial ID
NCT03560908
Treatments Being Tested
The AML18 Trial will evaluate several relevant therapeutic questions in Acu...
Status
Unknown
Location
Aalborg University Hospital
Start Date
2014-10-30
Trial ID
NCT02272478
Association group of therapeutic specialities authorized in a remission ind...
Status
Completed
Location
Hospital de la Ribera
Start Date
1998-07
Trial ID
NCT00487448
This phase I trial studies the side effects and best dose of ivosidenib whe...
Status
Terminated
Location
Northwestern University
Start Date
2020-12-21
Trial ID
NCT04250051
Treatments Being Tested
This phase 2 clinical trial investigates the effectiveness of cytokine-indu...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-06-30
Trial ID
NCT04354025
Treatments Being Tested